November 29, 2022

By

Polypill Medicine

A “polypill” is a pill that contains a combination of multiple drugs that are often used to treat heart disease and high blood pressure. Credit: McMaster University

Leading cardiologist experts believe that polypills could avoid millions of premature deaths, heart attacks, and strokes.

According to two top cardiologists in a commentary published in

“Despite substantial scientific evidence of the high effectiveness, safety, and affordability of the polypill, few such combined products are available, and in the few countries where they are available, use is low,” says Professor Fausto Pinto, President of the World Heart Federation.

“This systemic failure is a global tragedy, as many premature deaths from CVD could be avoided,” says Professor Salim Yusuf, Executive Director of the Population Health Research Institute (PHRI) and Professor Emeritus of Medicine at McMaster University.

Every year, about 54 million individuals suffer from cardiovascular disease; one-third of them die as a result of CVD, with 80 percent of them residing in low- and middle-income countries.

Most heart attacks and strokes occur in patients who have never had CVD, implying that primary prevention of the first heart attack or stroke is important. Secondary prevention is also important for individuals who already have CVD, although it does not have the same impact.

“The current strategy for primary and secondary prevention of CVD has only been modestly successful in most countries, including high-income countries. Even in these countries, fewer than half of patients with prior CVD, and fewer than 20% without prior CVD, receive effective preventive treatments,” says Professor Yusuf.

The polypill, also known as fixed-dose combination (FDC) therapy – with the combination of blood pressure lowering agents, a statin for lowering LDL cholesterol, and low-dose aspirin – was proposed in the early 2000s as a means to reduce CVD substantially and at low cost.

“The answer is now clear and resounding, with data from three independent, large, and long-term trials in primary prevention and one in secondary prevention showing its life-saving significance,” says Yusuf, whose various publications have shown that heart attacks and strokes were cut by 35 to 50 percent by using a polypill.

“It is time to use the polypill widely to save millions of lives each year,” says Professor Pinto. He and Professor Yusuf recommend the following new strategies:

  1. Encourage large pharmaceutical companies to invest in developing and testing polypills – in particular, newer polypills with larger blood pressure lower effects (such as combining low doses of 3 or 4 classes of drugs with statins and low doses of aspirin). Manufacturing with generic components, and marketing polypills at locally sensitive prices, would ensure affordability while maintaining profitability for the companies, thereby enhancing use by the majority of people around the world.
  2. Include polypills in the WHO’s Essential Medicines List, and in guidelines for both primary and secondary prevention of CVD is an important next step. “This would encourage governments and insurance companies, especially in low-income and middle-income countries to include in their formularies, and clinicians to recommend its use,” Pinto and Yusuf write.
  3. Combine the polypill with lifestyle advice for CVD prevention delivered by trained non-physician health workers (NPHWs) – not meant as a replacement for physicians who can use their advanced skills on managing individuals with more complex conditions – thus a combined strategy that would help many more people.

Reference: “The polypill: from concept and evidence to implementation” by Salim Yusuf and Fausto J Pinto, 12 October 2022, The Lancet.
DOI: 10.1016/S0140-6736(22)01847-5

A “polypill” is a pill that contains a combination of multiple drugs that are often used to treat heart disease and high blood pressure. Credit: McMaster University
According to two top cardiologists in a commentary published in

Every year, about 54 million individuals suffer from cardiovascular disease; one-third of them die as a result of CVD, with 80 percent of them residing in low- and middle-income countries.
Most heart attacks and strokes occur in patients who have never had CVD, implying that primary prevention of the first heart attack or stroke is important. Secondary prevention is also important for individuals who already have CVD, although it does not have the same impact.
“The current strategy for primary and secondary prevention of CVD has only been modestly successful in most countries, including high-income countries. Even in these countries, fewer than half of patients with prior CVD, and fewer than 20% without prior CVD, receive effective preventive treatments,” says Professor Yusuf.
The polypill, also known as fixed-dose combination (FDC) therapy – with the combination of blood pressure lowering agents, a statin for lowering LDL cholesterol, and low-dose aspirin – was proposed in the early 2000s as a means to reduce CVD substantially and at low cost.
“The answer is now clear and resounding, with data from three independent, large, and long-term trials in primary prevention and one in secondary prevention showing its life-saving significance,” says Yusuf, whose various publications have shown that heart attacks and strokes were cut by 35 to 50 percent by using a polypill.
“It is time to use the polypill widely to save millions of lives each year,” says Professor Pinto. He and Professor Yusuf recommend the following new strategies:
Reference: “The polypill: from concept and evidence to implementation” by Salim Yusuf and Fausto J Pinto, 12 October 2022, The Lancet.
DOI: 10.1016/S0140-6736(22)01847-5


Health

Heart Attacks and Strokes Can Be Cut by Up to 40% With Aspirin and Polypill Daily

Health

Cardiovascular Disease Deaths in Asia Are Rapidly Increasing

Health

Combo Therapy Cuts Risk of Heart Attacks and Strokes by More Than 50%

Health

Why You Shouldn’t Use Aspirin While on a Blood Thinner

Health

Aspirin Linked With Increased Risk of Heart Failure in New Study

Health

Aspirin Use Significantly Reduces Risk of Death in Hospitalized COVID-19 Patients

Health

American Heart Association: Sleep Duration Is Essential Component for Heart and Brain Health

Health

Heart Disease Among NYC Firefighters Linked to 9/11 World Trade Center Exposure

Why are you so shocked that Pharmaceutical companies only make things with high profit margins. Have you seen the difference in ingredients between English Heinz Ketchup and American Heinz Ketchup? Take a look sometime.
Let’s see: fentanyl, Chinese dust filler, etc…
Yup, another ChineseNewsNetwork ad fest, billions for pharma & countless deaths… It should be called “fauxchi pills”
Email address is optional. If provided, your email will not be published or shared.









SciTechDaily: Home of the best science and technology news since 1998. Keep up with the latest scitech news via email or social media.
  > Subscribe Free to Email Digest

November 21, 2022

Significant Post-COVID Brain Abnormalities Revealed by Special MRI

Scientists uncovered brain changes in patients up to six months after they recovered from COVID-19 by using a special type of MRI. This is according…

Read More

Scientists uncovered brain changes in patients up to six months after they recovered from COVID-19 by using a special type of MRI. This is according…
November 21, 2022

Can Stress Influence Your Appetite? A Johns Hopkins Study Reveals That It’s All in Your Head

November 21, 2022

Behold! NASA’s Artemis I Orion Close Flyby of the Moon

November 21, 2022

Evading Volcanic Disaster: Monitoring “Frothy” Magma Gases for Eruption Signals

November 21, 2022

Pain Relievers Like Ibuprofen and Naproxen May Worsen Arthritis Inflammation

November 20, 2022

Hubble Spots a Titanic Stellar Collision That Rattles Space and Time

November 20, 2022

Considered Impossible – New Study of 5 Million People Reveals Genetic Links to Height

November 20, 2022

More Successful Than Ketamine – A Shocking Depression Treatment

Copyright © 1998 – 2022 SciTechDaily. All Rights Reserved.

source

Leave a Reply

Your email address will not be published.